Academic Journal
Cardiac Surgery for Treatment of COVID-19-Associated Infectious Endocarditis
| العنوان: | Cardiac Surgery for Treatment of COVID-19-Associated Infectious Endocarditis |
|---|---|
| المؤلفون: | Taghizadeh-Waghefi, Ali, Petrov, Asen, Wilbring, Manuel, Alexiou, Konstantin, Kappert, Utz, Matschke, Klaus, Tugtekin, Sems-Malte |
| المصدر: | The Texas Heart Institute Journal |
| بيانات النشر: | DigitalCommons@TMC |
| سنة النشر: | 2023 |
| المجموعة: | Houston Academy of Medicine-Texas Medical Center (HAM-TMC): DigitalCommons@The Texas Medical Center |
| مصطلحات موضوعية: | Humans, Male, Middle Aged, Female, COVID-19, SARS-CoV-2, Endocarditis, Bacterial, Cardiac Surgical Procedures, Cardiology, Cardiovascular Diseases, Diseases, Medical Specialties, Medicine and Health Sciences |
| الوصف: | BACKGROUND: Significant uncertainty exists about the optimal timing of surgery for infectious endocarditis (IE) surgery in patients with active SARS-CoV-2 infection. This case series and a systematic review of the literature were carried out to evaluate the timing of surgery and postsurgical outcomes for patients with COVID-19-associated IE. METHODS: The PubMed database was searched for reports published from June 20, 2020, to June 24, 2021, that contained the terms infective endocarditis and COVID-19. A case series of 8 patients from the authors' facility was also added. RESULTS: A total of 12 cases were included, including 4 case reports that met inclusion criteria in addition to a case series of 8 patients from the authors' facility. Mean (SD) patient age was 61.9 (17.1) years, and patients were predominantly male (91.7%). Being overweight was the main comorbidity among patients studied (7/8 [87.5%]). Among all patients evaluated in this study, dyspnea (n = 8 [66.7%]) was the leading symptom, followed by fever (n = 7 [58.3%]). Enterococcus faecalis and Staphylococcus aureus caused 75.0% of COVID-19-associated IE. The mean (SD) time to surgery was 14.5 (15.6) days (median, 13 days). In-hospital and 30-day mortality for all evaluated patients was 16.7% (n = 2). CONCLUSION: Clinicians must carefully assess patients diagnosed with COVID-19 to prevent missing underlying diseases such as IE. If IE is suspected, clinicians should avoid postponement of crucial diagnostic and treatment steps. |
| نوع الوثيقة: | text |
| وصف الملف: | application/pdf |
| اللغة: | English |
| Relation: | https://digitalcommons.library.tmc.edu/texasheartinstituejournal/9; https://digitalcommons.library.tmc.edu/context/texasheartinstituejournal/article/1011/viewcontent/i1526_6702_50_2_e227884.pdf |
| DOI: | 10.14503/THIJ-22-7884 |
| الاتاحة: | https://digitalcommons.library.tmc.edu/texasheartinstituejournal/9 https://doi.org/10.14503/THIJ-22-7884 https://digitalcommons.library.tmc.edu/context/texasheartinstituejournal/article/1011/viewcontent/i1526_6702_50_2_e227884.pdf |
| Rights: | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
| رقم الانضمام: | edsbas.F08E7094 |
| قاعدة البيانات: | BASE |
| DOI: | 10.14503/THIJ-22-7884 |
|---|